HCPCS C-Codes
Temporary Codes for Use with Outpatient Prospective Payment System

  • C9149

    Injection, teplizumab-mzwv, 5 mcg

  • C9150

    Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

  • C9151

    Injection, pegcetacoplan, 1 mg

  • C9152

    Injection, aripiprazole, (abilify asimtufii), 1 mg

  • C9153

    Injection, amisulpride, 1 mg

  • C9154

    Injection, buprenorphine extended-release (brixadi), 1 mg

  • C9155

    Injection, epcoritamab-bysp, 0.16 mg

  • C9156

    Flotufolastat f 18, diagnostic, 1 millicurie

  • C9157

    Injection, tofersen, 1 mg

  • C9158

    Injection, risperidone, (uzedy), 1 mg
  • Continued

  • C9159

    Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity

  • C9160

    Injection, daxibotulinumtoxina-lanm, 1 unit

  • C9161

    Injection, aflibercept hd, 1 mg

  • C9162

    Injection, avacincaptad pegol, 0.1 mg

  • C9163

    Injection, talquetamab-tgvs, 0.25 mg

  • C9164

    Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)

  • C9165

    Injection, elranatamab-bcmm, 1 mg

  • C9166

    Injection, secukinumab, intravenous, 1 mg

  • C9167

    Injection, adamts13, recombinant-krhn, 10 iu

  • C9168

    Injection, mirikizumab-mrkz, 1 mg

  • C9169

    Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram

  • C9170

    Injection, tarlatamab-dlle, 1 mg

  • C9171

    Injection, pegulicianine, 1 mg

  • C9172

    Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose

  • C9173

    Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram

  • C9174

    Injection, datopotamab deruxtecan-dlnk, 1 mg

  • C9175

    Injection, treosulfan, 50 mg

  • C9176

    Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose

  • C9248

    Injection, clevidipine butyrate, 1 mg

  • C9250

    Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
  • Continued

  • C9254

    Injection, lacosamide, 1 mg

  • C9257

    Injection, bevacizumab, 0.25 mg

  • C9275

    Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose

  • C9285

    Lidocaine 70 mg/tetracaine 70 mg, per patch

  • C9290

    Injection, bupivacaine liposome, 1 mg

  • C9293

    Injection, glucarpidase, 10 units

  • C9300

    Injection, indigotindisulfonate sodium, 1 mg

  • C9301

    Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • C9302

    Injection, zanidatamab-hrii, 2 mg

  • C9303

    Injection, zolbetuximab-clzb, 1 mg

  • C9304

    Injection, marstacimab-hncq, 0.5 mg

  • C9305

    Injection, nipocalimab-aahu, 3 mg

  • C9306

    Injection, telisotuzumab vedotin-tllv, 1 mg

  • C9307

    Injection, linvoseltamab-gcpt, 1 mg   Discontinued

  • C9308

    Injection, carboplatin (avyxa), 1 mg   Discontinued

  • C9309

    Injection, onasemnogene abeparvovec-brve, per treatment   New

  • C9349

    Puraply, and puraply antimicrobial, any type, per square centimeter

  • C9352

    Microporous collagen implantable tube (neuragen nerve guide), per centimeter length

  • C9353

    Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length

  • C9354

    Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter